Novel Technologies for Understanding Metabolomic Communications between Host and Microbiota
Microbiome Times
Novel Technologies for Understanding Metabolomic Communications between Host and Microbiota
17:35
Standardization in microbiome measurements Considerations from sampling to analysis
Microbiome Times
Standardization in microbiome measurements Considerations from sampling to analysis
1:01:36
Toward Clinical Utility of Metagenomic Data: Interview with Dr Joël Doré
Microbiome Times
Toward Clinical Utility of Metagenomic Data: Interview with Dr Joël Doré
6:37
Interview with Jim Weston and Stephen Conafay of the Microbiome Therapeutics Innovation Group
Microbiome Times
Interview with Jim Weston and Stephen Conafay of the Microbiome Therapeutics Innovation Group
5:04
IV MTIG V2
Microbiome Times
IV MTIG V2
5:04
Novel Technologies for Understanding Metabolomic Communications between Host and Microbiota
Microbiome Times
Novel Technologies for Understanding Metabolomic Communications between Host and Microbiota
24:19
Interview with Xavier Duportet, CEO & Co-founder, Eligo Bioscience
Microbiome Times
Interview with Xavier Duportet, CEO & Co-founder, Eligo Bioscience
5:56
Webinar: Improving Ulcerative Colitis Symptoms with Probiotics - Systematic Review & Meta-Analysis
Microbiome Times
Webinar: Improving Ulcerative Colitis Symptoms with Probiotics - Systematic Review & Meta-Analysis
32:12
Investing in the Microbiome: A discussion between Malcolm Kendall and Isabelle de Cremoux
Microbiome Times
Investing in the Microbiome: A discussion between Malcolm Kendall and Isabelle de Cremoux
6:33
Modulating the Preterm Gut Microbiota: An Interview with Dr Lindsay Hall
Microbiome Times
Modulating the Preterm Gut Microbiota: An Interview with Dr Lindsay Hall
6:00
Interview With Aoife Brennan, CEO, Synlogic Inc
Microbiome Times
Interview With Aoife Brennan, CEO, Synlogic Inc
5:44